XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2024   49,079,876      
Beginning balance at Jan. 31, 2024 $ 130,421 $ 0 $ 621,024 $ 56 $ (490,659)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock upon exercise of stock options (in shares)   542,393      
Issuance of common stock upon exercise of stock options 4,136   4,136    
Issuance of common stock in connection with employee stock purchase plan (in shares)   123,778      
Issuance of common stock in connection with employee stock purchase plan 1,795   1,795    
Vesting of restricted stock units (in shares)   1,537,046      
Stock-based compensation 31,210   31,210    
Net unrealized gains (losses) on investments (29)     (29)  
Net loss (40,890)       (40,890)
Ending balance (in shares) at Jul. 31, 2024   51,283,093      
Ending balance at Jul. 31, 2024 126,643 $ 0 658,165 27 (531,549)
Beginning balance (in shares) at Apr. 30, 2024   50,220,260      
Beginning balance at Apr. 30, 2024 129,062 $ 0 640,931 (215) (511,654)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock upon exercise of stock options (in shares)   136,338      
Issuance of common stock upon exercise of stock options 842   842    
Vesting of restricted stock units (in shares)   926,495      
Stock-based compensation 16,392   16,392    
Net unrealized gains (losses) on investments 242     242  
Net loss (19,895)       (19,895)
Ending balance (in shares) at Jul. 31, 2024   51,283,093      
Ending balance at Jul. 31, 2024 $ 126,643 $ 0 658,165 27 (531,549)
Beginning balance (in shares) at Jan. 31, 2025 53,078,742 53,078,742      
Beginning balance at Jan. 31, 2025 $ 127,616 $ 0 692,812 116 (565,312)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock upon exercise of stock options (in shares)   762,875      
Issuance of common stock upon exercise of stock options 8,854   8,854    
Issuance of common stock in connection with employee stock purchase plan (in shares)   118,609      
Issuance of common stock in connection with employee stock purchase plan 1,424   1,424    
Vesting of restricted stock units (in shares)   1,288,351      
Stock-based compensation 27,698   27,698    
Net unrealized gains (losses) on investments (118)     (118)  
Net loss $ (41,465)       (41,465)
Ending balance (in shares) at Jul. 31, 2025 55,248,577 55,248,577      
Ending balance at Jul. 31, 2025 $ 124,009 $ 0 730,788 (2) (606,777)
Beginning balance (in shares) at Apr. 30, 2025   54,041,260      
Beginning balance at Apr. 30, 2025 126,150 $ 0 708,941 200 (582,991)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock upon exercise of stock options (in shares)   556,116      
Issuance of common stock upon exercise of stock options 7,635   7,635    
Vesting of restricted stock units (in shares)   651,201      
Stock-based compensation 14,212   14,212    
Net unrealized gains (losses) on investments (202)     (202)  
Net loss $ (23,786)       (23,786)
Ending balance (in shares) at Jul. 31, 2025 55,248,577 55,248,577      
Ending balance at Jul. 31, 2025 $ 124,009 $ 0 $ 730,788 $ (2) $ (606,777)